Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioInvent, Alligator Enter Development and Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

BioInvent, Alligator Enter Development and Mfg. Pact

To provide process development and manufacturing services for Alligator’s bispecific antibody

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioInvent International has signed an agreement with Alligator Bioscience AB to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
 
The agreement includes payments for development services and GMP manufacturing for the upcoming clinical trial. Financial details were not disclosed.
 
“The agreement with Alligator to manufacture its new bispecific antibody ADC-1015 speaks to our leading expertise when it comes to manufacturing of antibodies. Our manufacturing facility will be upgraded during 2016, which includes installation of a Single Use Bioreactor (SUB). This enables delivery according to timelines defined by Alligator. The agreement is expected to generate revenues of more than SEK 20 million,” said Michael Oredsson, president and chief executive officer of BioInvent.
 
“We are pleased that BioInvent has committed to process development and manufacturing of the bispecific immune-activating antibody ADC-1015. BioInvent’s long experience and upgraded GMP certified manufacturing facility meet our needs for the coming clinical trial and will enable us to move ADC-1015 through to the clinic according to plan,” said Per Norlén, chief executive officer of Alligator Bioscience AB.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics